Molecular and clinical study of McArdle's disease in a cohort of 123 European patients. Identification of 20 novel mutations
- PMID: 21802952
- DOI: 10.1016/j.nmd.2011.07.002
Molecular and clinical study of McArdle's disease in a cohort of 123 European patients. Identification of 20 novel mutations
Abstract
McArdle's disease is the most common muscle glycogenosis. It is caused by the deficiency of myophosphorylase, encoded by the PYGM gene. We studied 123 patients previously diagnosed with McArdle's disease and we identified 20 novel mutations (10 missense and 3 nonsense mutations, 3 small deletions, 2 gross deletions and 2 small insertions). Most patients of this cohort belong to Spanish and French populations. This allowed us to determine the differences between the allelic frequencies of the common mutations R50X and G205S of these populations. The R50X has an allelic frequency in this cohort of about 61.7%, being 68.5% in French and 53.7% in Spanish patients. The G205S had a higher allelic frequency in the Spanish (10.2%) than in the French population (3.2%). Moreover, a clinical study of 91 patients was performed to establish both genotype-phenotype correlation and gender influence in the severity of the disease. We conclude that no genotype-phenotype correlation is evident and that no gender effect is related to the phenotype.
Copyright © 2011 Elsevier B.V. All rights reserved.
Similar articles
-
Molecular heterogeneity of myophosphorylase deficiency (McArdle's disease): a genotype-phenotype correlation study.Ann Neurol. 2001 Nov;50(5):574-81. Ann Neurol. 2001. PMID: 11706962
-
Molecular characterization of myophosphorylase deficiency (McArdle disease) in 34 patients from Southern France: identification of 10 new mutations. Absence of genotype-phenotype correlation.Neuromuscul Disord. 2007 Mar;17(3):235-41. doi: 10.1016/j.nmd.2006.12.014. Epub 2007 Feb 26. Neuromuscul Disord. 2007. PMID: 17324573
-
A proposed molecular diagnostic flowchart for myophosphorylase deficiency (McArdle disease) in blood samples from Spanish patients.Hum Mutat. 2007 Feb;28(2):203-4. doi: 10.1002/humu.9474. Hum Mutat. 2007. PMID: 17221871
-
McArdle Disease: Update of Reported Mutations and Polymorphisms in the PYGM Gene.Hum Mutat. 2015 Jul;36(7):669-78. doi: 10.1002/humu.22806. Epub 2015 Jun 3. Hum Mutat. 2015. PMID: 25914343 Review.
-
Molecular genetics of McArdle's disease.Curr Neurol Neurosci Rep. 2007 Jan;7(1):84-92. doi: 10.1007/s11910-007-0026-2. Curr Neurol Neurosci Rep. 2007. PMID: 17217859 Review.
Cited by
-
McArdle Disease and Exercise Physiology.Biology (Basel). 2014 Feb 25;3(1):157-66. doi: 10.3390/biology3010157. Biology (Basel). 2014. PMID: 24833339 Free PMC article.
-
Genotypic and phenotypic features of all Spanish patients with McArdle disease: a 2016 update.BMC Genomics. 2017 Nov 14;18(Suppl 8):819. doi: 10.1186/s12864-017-4188-2. BMC Genomics. 2017. PMID: 29143597 Free PMC article.
-
McArdle's Disease: A Differential Diagnosis of Metabolic Myopathies.Cureus. 2024 Sep 23;16(9):e70000. doi: 10.7759/cureus.70000. eCollection 2024 Sep. Cureus. 2024. PMID: 39318660 Free PMC article. Review.
-
The significance of clinical and laboratory features in the diagnosis of glycogen storage disease type v: a case report.J Korean Med Sci. 2014 Jul;29(7):1021-4. doi: 10.3346/jkms.2014.29.7.1021. Epub 2014 Jul 11. J Korean Med Sci. 2014. PMID: 25045239 Free PMC article.
-
Clinical and molecular characterization of McArdle's disease in Brazilian patients.Neuromolecular Med. 2013 Sep;15(3):470-5. doi: 10.1007/s12017-013-8233-2. Epub 2013 May 8. Neuromolecular Med. 2013. PMID: 23653251
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources